Please assess the completion status of the following clinical trial:

Trial Title: Nutritional Supplementation in the Elderly With Weight Loss

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female age 65 and older~* Non-smokers~* Weight loss \>3% body weight over 6-12 months~* BMI ≤ 25~* Living independently or in an assisted living facility~Exclusion Criteria:~* Medical conditions that would lead to weight loss~  * Active cancer undergoing treatment (chemotherapy, radiation therapy, or planned surgical intervention)~ * CKD stage IV-V (eGFR \<30) based on medical records within the last 12 months~ * Presence of dysphagia or odynophagia~ * Actively taking blood thinner such as Warfarin~ * Known history of cirrhosis with presence of ascites~ * History of a surgical procedure for weight loss (e.g. gastroplasty, gastric bypass, gastrectomy or partial gastrectomy, lap-band)~ * Any abnormal lab findings outside of normal limits as determined by the investigator~* Dietary conditions~  * Diet restrictions including vegetarianism, veganism, soy-free diet,~ * Fish and/or fish oil allergy or intolerance~ * Milk allergy excluding lactose intolerance~ * Follows a kosher diet~* Medications~  * Use of appetite stimulants (including megestrol, dronabinol and cyproheptadine).~ * Does not include medications used for depression (e.g. mirtazapine, paxil) if patient has been on a stable dose of this medication for at least 3 months prior to the start of this study~ * If participant is already taking a fish oil supplement, he/she must be willing to either stop the supplement or take the supplement the investigators are using in the study depending on the randomization assignment~* Additional~  * Patient has implantable device such as a pacemaker or ICD~ * Unable to complete 6-minute walk test at baseline~ * Hospitalization within the last 30 days~ * Participation in a therapeutic research study within 30 days of baseline~ * Living in a skilled nursing facility or long-term care facility~ * Any other medical condition that principal investigator or co-investigators deem would preclude the patient from study participation

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Supplement + Fish Oil (Type: EXPERIMENTAL): Participants will mix 5 scoops of powdered nutrition supplement with 8 oz of cold water (2x/day). The supplemental shake will be consumed on two separate occasions daily. Omega-3 fish oil supplement is in capsule form for intake once daily.~The NutraWell nutrition powder and OmegaRich fish oil supplement will be provided by and distributed from DoWell Laboratories (Irvine, CA - USA).
- Control (Type: NO_INTERVENTION): No dietary supplements. Participants will continue current intake.

Based on this trial design, predict the completion outcome and termination type (if applicable).